inclusion criteria: * adults 18 years of age at the time of screening or \>= 40 years and presenting at least one comorbidity : high blood pressure; a known obesity and/ or a known and treated diabete. * sars-cov-2 infection confirmed by molecular biology (rt-pcr on a nasopharyngeal or oropharyngeal swab) or by antigen test validated in the country according to national guidelines * a viral syndrome with or without uncomplicated pneumonia, defined as blood oxygen saturation level (spo2) \>=94%. * mild covid-19 symptoms with an onset \< 7 days before inclusion. * signed written consent from the patient or his/her representative. * no need an oxygen therapy according to international guidelines (who progression scale, grade 2 to 4) * accepting and having the ability to be reached by telephone throughout the study. * having designated a contact person who can be contacted in case of emergency. * accepted to be reached by phone along throughout the study

inclusion criteria: * adults 18 years of age at the time of screening or \>= 40 years and presenting at least one comorbidity : high blood pressure; a known obesity and/ or a known and treated diabete. * sars-cov-2 infection confirmed by molecular biology (rt-pcr on a nasopharyngeal or oropharyngeal swab) or by antigen test validated in the country according to national guidelines * a viral syndrome with or without uncomplicated pneumonia, defined as blood oxygen saturation level (spo2) \>=94%. * mild covid-19 symptoms with an onset \< 7 days before inclusion. * signed written consent from the patient or his/her representative. * no need an oxygen therapy according to international guidelines (who progression scale, grade 2 to 4) * accepting and having the ability to be reached by telephone throughout the study. * having designated a contact person who can be contacted in case of emergency. * accepted to be reached by phone along throughout the study

inclusion criteria: adults 18 years of age at the time of screening or >= 40 years and presenting at least one comorbidity : high blood pressure; a known obesity and/ or a known and treated diabete. sars-cov-2 infection confirmed by molecular biology (rt-pcr on a nasopharyngeal or oropharyngeal swab) or by antigen test validated in the country according to national guidelines a viral syndrome with or without uncomplicated pneumonia, defined as blood oxygen saturation level (spo2) >=94%. mild covid-19 symptoms with an onset < 7 days before inclusion. signed written consent from the patient or his/her representative. no need an oxygen therapy according to international guidelines (who progression scale, grade 2 to 4) accepting and having the ability to be reached by telephone throughout the study. having designated a contact person who can be contacted in case of emergency. accepted to be reached by phone along throughout the study

inclusion criteria: adults 18 years of age at the time of screening or >= 40 years and presenting at least one comorbidity : high blood pressure; a known obesity and/ or a known and treated diabete. sars-cov-2 infection confirmed by molecular biology (rt-pcr on a nasopharyngeal or oropharyngeal swab) or by antigen test validated in the country according to national guidelines a viral syndrome with or without uncomplicated pneumonia, defined as blood oxygen saturation level (spo2) >=94%. mild covid-19 symptoms with an onset < 7 days before inclusion. signed written consent from the patient or his/her representative. no need an oxygen therapy according to international guidelines (who progression scale, grade 2 to 4) accepting and having the ability to be reached by telephone throughout the study. having designated a contact person who can be contacted in case of emergency. accepted to be reached by phone along throughout the study

inclusion criteria: - adults 18 years of age at the time of screening or >= 40 years and presenting at least one comorbidity : high blood pressure; a known obesity and/ or a known and treated diabete. - covid-19 confirmed by molecular biology - a viral syndrome with or without uncomplicated pneumonia, defined as blood oxygen saturation level (spo2) >=94%. - mild covid-19 symptoms with an onset < 7 days before inclusion. - signed written consent from the patient or his/her representative. - no need an oxygen therapy according to international guidelines (who progression scale, grade 2 to 4) - accepting and having the ability to be reached by telephone throughout the study. - having designated a contact person who can be contacted in case of emergency. - accepted to be reached by phone along throughout the study

inclusion criteria: - adults 18 years of age at the time of screening or >= 40 years and presenting at least one comorbidity : high blood pressure; a known obesity and/ or a known and treated diabete. - covid-19 confirmed by molecular biology - a viral syndrome with or without uncomplicated pneumonia, defined as blood oxygen saturation level (spo2) >=94%. - mild covid-19 symptoms with an onset < 7 days before inclusion. - signed written consent from the patient or his/her representative. - no need an oxygen therapy according to international guidelines (who progression scale, grade 2 to 4) - accepting and having the ability to be reached by telephone throughout the study. - having designated a contact person who can be contacted in case of emergency. - accepted to be reached by phone along throughout the study